Search Results - "Parihar, Suraj P."

Refine Results
  1. 1
  2. 2

    Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection by Nafiz, Tanvir Noor, Sankar, Poornima, Mishra, Lokesh K., Rousseau, Robert P., Saqib, Mohd, Subbian, Selvakumar, Parihar, Suraj P., Mishra, Bibhuti B.

    Published in Scientific reports (09-10-2024)
    “…Formyl peptide receptors (FPR), part of the G-protein coupled receptor superfamily, are pivotal in directing phagocyte migration towards chemotactic signals…”
    Get full text
    Journal Article
  3. 3

    Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis by Guler, Reto, Ozturk, Mumin, Sabeel, Solima, Motaung, Bongani, Parihar, Suraj P, Thienemann, Friedrich, Brombacher, Frank

    Published in Frontiers in immunology (20-10-2021)
    “…Globally, more than 10 million people developed active tuberculosis (TB), with 1.4 million deaths in 2020. In addition, the emergence of drug-resistant strains…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The divergent outcome of IL-4Rα signalling on Foxp3 T regulatory cells in listeriosis and tuberculosis by Chia, Julius E, Rousseau, Robert P, Ozturk, Mumin, Poswayo, Sibongiseni K L, Lucas, Rodney, Brombacher, Frank, Parihar, Suraj P

    Published in Frontiers in immunology (17-10-2024)
    “…Forkhead box P3 (Foxp3) T regulatory cells are critical for maintaining self-tolerance, immune homeostasis, and regulating the immune system. We investigated…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Evaluation of Berberine as an Adjunct to TB Treatment by Ozturk, Mumin, Chia, Julius E, Hazra, Rudranil, Saqib, Mohd, Maine, Rebeng A, Guler, Reto, Suzuki, Harukazu, Mishra, Bibhuti B, Brombacher, Frank, Parihar, Suraj P

    Published in Frontiers in immunology (20-10-2021)
    “…Tuberculosis (TB) is the global health problem with the second highest number of deaths from a communicable disease after COVID-19. Although TB is curable,…”
    Get full text
    Journal Article
  8. 8

    Spatial Metagenomic Analysis in Understanding the Microbial Diversity of Thar Desert by Parihar, Jagdish, Parihar, Suraj P, Suravajhala, Prashanth, Bagaria, Ashima

    Published in Biology (Basel, Switzerland) (17-03-2022)
    “…The arid and semi-arid regions of Rajasthan are one of the most extreme biomes of India, possessing diverse microbial communities that exhibit immense…”
    Get full text
    Journal Article
  9. 9
  10. 10

    IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice by Parihar, Suraj P., Ozturk, Mumin, Höft, Maxine A., Chia, Julius E., Guler, Reto, Keeton, Roanne, van Rensburg, Ilana C., Loxton, Andre G., Brombacher, Frank

    Published in Frontiers in immunology (15-06-2021)
    “…In tuberculosis, T cell-mediated immunity is extensively studied whilst B cells received limited attention in human and mice. Of interest, Mycobacterium…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice by Jones, Shelby-Sara, Ozturk, Mumin, Kieswetter, Nathan Scott, Poswayo, Sibongiseni K L, Hazra, Rudranil, Tamgue, Ousman, Parihar, Suraj P, Suzuki, Harukazu, Brombacher, Frank, Guler, Reto

    Published in Frontiers in immunology (02-09-2022)
    “…Lymphoblastic leukemia 1 (Lyl1) is a well-studied transcription factor known to exhibit oncogenic potential in various forms of leukemia with pivotal roles in…”
    Get full text
    Journal Article
  13. 13

    Statins: a viable candidate for host-directed therapy against infectious diseases by Parihar, Suraj P., Guler, Reto, Brombacher, Frank

    Published in Nature reviews. Immunology (01-02-2019)
    “…Statins were first identified over 40 years ago as lipid-lowering drugs and have been remarkably effective in treating cardiovascular diseases. As research…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection by Hurdayal, Ramona, Nieuwenhuizen, Natalie E, Revaz-Breton, Mélanie, Smith, Liezel, Hoving, Jennifer C, Parihar, Suraj P, Reizis, Boris, Brombacher, Frank

    Published in PLoS pathogens (01-10-2013)
    “…In BALB/c mice, susceptibility to infection with the intracellular parasite Leishmania major is driven largely by the development of T helper 2 (Th2) responses…”
    Get full text
    Journal Article
  16. 16

    Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape by Parihar, Suraj P, Guler, Reto, Lang, Dirk M, Suzuki, Harukazu, Marais, A David, Brombacher, Frank

    Published in PloS one (24-09-2013)
    “…Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are…”
    Get full text
    Journal Article
  17. 17

    IL-4Rα-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice by Guler, Reto, Parihar, Suraj P, Savvi, Suzana, Logan, Erin, Schwegmann, Anita, Roy, Sugata, Nieuwenhuizen, Natalie E, Ozturk, Mumin, Schmeier, Sebastian, Suzuki, Harukazu, Brombacher, Frank

    Published in PloS one (19-03-2015)
    “…Classical activation of macrophages (caMph or M1) is crucial for host protection against Mycobacterium tuberculosis (Mtb) infection. Evidence suggests that…”
    Get full text
    Journal Article
  18. 18

    Viral Apoptosis Evasion via the MAPK Pathway by Use of a Host Long Noncoding RNA by Barichievy, Samantha, Naidoo, Jerolen, Boullé, Mikaël, Scholefield, Janine, Parihar, Suraj P, Coussens, Anna K, Brombacher, Frank, Sigal, Alex, Mhlanga, Musa M

    “…An emerging realization of infectious disease is that pathogens can cause a high incidence of genetic instability within the host as a result of…”
    Get full text
    Journal Article
  19. 19

    Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model by Hayford, Frank E A, Ozturk, Mumin, Dolman, Robin C, Blaauw, Renee, Nienaber, Arista, Loots, Du Toit, Brombacher, Frank, Smuts, Cornelius M, Parihar, Suraj P, Malan, Linda

    Published in Frontiers in immunology (28-04-2021)
    “…Advancement in the understanding of inflammation regulation during tuberculosis (TB) treatment has led to novel therapeutic approaches being proposed. The use…”
    Get full text
    Journal Article
  20. 20